文献速递血脂与心血管预防

他汀类药物与老年美国退伍军人无新发衰弱生存的关联

Statins and survival free of incident frailty among older US veterans.
PubMed 文献 · Eur Heart J · 2026-06-10

平均随访5.3年,他汀起始者新发衰弱风险显著低于未起始者(HR 0.76,95%CI 0.75-0.76),在衰弱前期退伍军人中结果相似。

要点

  • 在老年退伍军人中,起始他汀与新发衰弱或死亡风险降低相关。
  • 倾向评分加权后,他汀起始者新发衰弱风险比为0.76(95%CI 0.75-0.76)。
  • 基线衰弱前期退伍军人中亦观察到相似关联。

核心结论

  • 在老年美国退伍军人中,起始他汀与较低的新发衰弱或死亡复合终点风险显著相关,包括基线衰弱前期者。

研究设计与样本

  • 采用重叠倾向评分加权处理适应证混淆,拟合Cox回归模型分析他汀使用与新发衰弱(删失死亡)的关联。
  • 对基线衰弱前期(VA-FI评分0.1-0.2)退伍军人进行类似分析。

主要发现

  • 未调整事件率:他汀起始者153.1例/1000人年,未起始者111.4例/1000人年。
  • 倾向评分加权后,新起始他汀者新发衰弱风险低于未起始者(HR 0.76,95%CI 0.75-0.76)。
  • 在衰弱前期退伍军人中观察到相似结果。

临床怎么用

  • 对老年、基线无衰弱或衰弱前期的他汀适格退伍军人,起始他汀可能同时降低新发衰弱或死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Frailty is associated with cardiovascular disease (CVD) through shared pathophysiology and risk factors, and frailty is a known modifiable risk factor for CVD. Statins reduce CVD risk and have anti-inflammatory properties that may lower the risk of frailty, though this has not been comprehensively examined. METHODS: Older US veterans (aged ≥67 years) who were statin naïve and received regular care in the Veteran Affairs (VA) medical system from 2002 to 2018 were included. Veterans who were frail at baseline based on a validated 31-item VA-Frailty Index (VA-FI) were excluded (scores >0.2). Data were linked to Medicare and Medicaid. Overlap propensity score weighting (PSW) was used to address confounding by indication. Cox regression models were fit to examine the association of statin use with the composite outcome of incident frailty with censoring at death. Similar analyses were conducted on pre-frail veterans (VA-FI score of 0.1-0.2). RESULTS: Of 987 301 veterans included in the study population (age 72 ± 6 years; 98% men; 87% white), 290 729 initiated statins during the study period. During a mean follow-up of 5.3 (SD 4.1) years, 636 195 incident frailty events occurred, representing unadjusted event rates of 153.1 events per 1000 person-years among statin initiators and 111.4 events per 1000 person-years in non-initiators. After PSW, new statin initiators were less likely to experience incident frailty (hazard ratio 0.76, 95% confidence interval 0.75-0.76) compared to non-initiators. Similar results were seen in pre-frail veterans. CONCLUSIONS: Statin initiation was associated with a significantly lower risk of incident frailty or death among older US veterans including those who were pre-frail at baseline.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Qazi S, Charest B, Pajewski NM, et al. Statins and survival free of incident frailty among older US veterans. Eur Heart J. 2026. PMID: 42264468. doi:10.1093/eurheartj/ehag451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。